DA Davidson Comments on The Clorox Company’s Q4 2024 Earnings (NYSE:CLX)

The Clorox Company (NYSE:CLX) – Equities researchers at DA Davidson issued their Q4 2024 earnings per share (EPS) estimates for shares of Clorox in a report released on Wednesday, May 1st. DA Davidson analyst L. Weiser anticipates that the company will post earnings of $1.41 per share for the quarter. DA Davidson currently has a “Neutral” rating and a $162.00 price target on the stock. The consensus estimate for Clorox’s current full-year earnings is $5.85 per share. DA Davidson also issued estimates for Clorox’s FY2025 earnings at $6.03 EPS.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.38. The company had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. Clorox’s revenue was down 5.3% on a year-over-year basis. During the same period in the previous year, the firm posted $1.51 EPS.

CLX has been the subject of several other reports. The Goldman Sachs Group initiated coverage on Clorox in a report on Friday, March 1st. They issued a “sell” rating and a $140.00 price target for the company. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research note on Wednesday, April 17th. Evercore ISI lowered their price objective on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research note on Wednesday. Wells Fargo & Company lowered their price objective on shares of Clorox from $140.00 to $135.00 and set an “underweight” rating for the company in a research note on Thursday. Finally, Citigroup lowered their price objective on shares of Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a research note on Wednesday. Four research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $146.43.

Clorox Trading Down 1.0 %

Shares of CLX opened at $138.23 on Thursday. The stock has a fifty day moving average of $148.74 and a two-hundred day moving average of $143.08. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.57 and a current ratio of 0.90. The company has a market capitalization of $17.17 billion, a PE ratio of 71.62, a price-to-earnings-growth ratio of 2.08 and a beta of 0.44. Clorox has a fifty-two week low of $114.68 and a fifty-two week high of $176.24.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a $1.20 dividend. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.47%. Clorox’s dividend payout ratio (DPR) is presently 248.70%.

Institutional Investors Weigh In On Clorox

Several institutional investors and hedge funds have recently bought and sold shares of CLX. Fortitude Family Office LLC acquired a new stake in Clorox during the fourth quarter worth about $29,000. Venturi Wealth Management LLC grew its position in Clorox by 308.5% in the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock worth $29,000 after purchasing an additional 145 shares during the last quarter. Northwest Financial Advisors bought a new position in Clorox in the 4th quarter worth about $29,000. Core Wealth Advisors Inc. bought a new position in Clorox in the 4th quarter worth about $29,000. Finally, First United Bank & Trust bought a new position in shares of Clorox in the fourth quarter valued at approximately $31,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.